


Searching News Database: SpeBio
HSMN NewsFeed - 16 Jul 2008
BioAlliance Pharma suspends the Phase II/III trial of doxorubicin Transdrug(R) in primary liver cancer
BioAlliance Pharma suspends the Phase II/III trial of doxorubicin Transdrug(R) in primary liver cancer
HSMN NewsFeed - 23 Jun 2008
BioAlliance Pharma extends its Loramyc(TM) License to China with NovaMed Pharmaceuticals
BioAlliance Pharma extends its Loramyc(TM) License to China with NovaMed Pharmaceuticals
HSMN NewsFeed - 26 Mar 2008
BioAlliance Pharma Receives Market Approval for Loramyc(R) in Germany, Belgium and Luxemburg
BioAlliance Pharma Receives Market Approval for Loramyc(R) in Germany, Belgium and Luxemburg
HSMN NewsFeed - 9 Jan 2008
BioAlliance Pharma Receives Market Approval for Loramyc(R) in the United Kingdom and Denmark
BioAlliance Pharma Receives Market Approval for Loramyc(R) in the United Kingdom and Denmark
